Literature DB >> 15190107

Day-night changes in downstream regulatory element antagonist modulator/potassium channel interacting protein activity contribute to circadian gene expression in pineal gland.

Wolfgang A Link1, Fran Ledo, Begoña Torres, Malgorzata Palczewska, Torsten M Madsen, Magali Savignac, Juan P Albar, Britt Mellström, Jose R Naranjo.   

Abstract

The molecular mechanisms controlling the oscillatory synthesis of melatonin in rat pineal gland involve the rhythmic expression of several genes including arylalkylamine N-acetyltransferase (AA-NAT), inducible cAMP early repressor (ICER), and Fos-related antigen-2 (fra-2). Here we show that the calcium sensors downstream regulatory element antagonist modulator/potassium channel interacting protein (DREAM/KChIP)-3 and KChIP-1, -2 and -4 bind to downstream regulatory element (DRE) sites located in the regulatory regions of these genes and repress basal and induced transcription from ICER, fra-2 or AA-NAT promoters. Importantly, we demonstrate that the endogenous binding activity to DRE sites shows day-night oscillations in rat pineal gland and retina but not in the cerebellum. The peak of DRE binding activity occurs during the day period of the circadian cycle, coinciding with the lowest levels of fra-2, ICER, and AA-NAT transcripts. We show that a rapid clearance of DRE binding activity during the entry in the night period is related to changes at the posttranscriptional level of DREAM/KChIP. The circadian pattern of DREAM/KChIP activity is maintained under constant darkness, indicating that an endogenous clock controls DREAM/KChIP function. Our data suggest involvement of the family of DREAM repressors in the regulation of rhythmically expressed genes engaged in circadian rhythms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15190107      PMCID: PMC6729300          DOI: 10.1523/JNEUROSCI.1460-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

1.  Modulation of human Kv4.3/KChIP2 channel inactivation kinetics by cytoplasmic Ca2.

Authors:  Christiane Groen; Robert Bähring
Journal:  Pflugers Arch       Date:  2017-07-22       Impact factor: 3.657

2.  Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease.

Authors:  José R Naranjo; Hongyu Zhang; Diego Villar; Paz González; Xose M Dopazo; Javier Morón-Oset; Elena Higueras; Juan C Oliveros; María D Arrabal; Angela Prieto; Pilar Cercós; Teresa González; Alicia De la Cruz; Juan Casado-Vela; Alberto Rábano; Carmen Valenzuela; Marta Gutierrez-Rodriguez; Jia-Yi Li; Britt Mellström
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

3.  Transcriptional repressor DREAM regulates T-lymphocyte proliferation and cytokine gene expression.

Authors:  Magali Savignac; Belen Pintado; Alfonso Gutierrez-Adan; Malgorzata Palczewska; Britt Mellström; Jose R Naranjo
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

Review 4.  The rhythm and blues of gene expression in the rodent pineal gland.

Authors:  Magdalena Karolczak; Horst-Werner Korf; Jörg H Stehle
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

5.  Ca2+-activated nucleotidase 1, a novel target gene for the transcriptional repressor DREAM (downstream regulatory element antagonist modulator), is involved in protein folding and degradation.

Authors:  Tito Calì; Laura Fedrizzi; Denis Ottolini; Rosa Gomez-Villafuertes; Britt Mellström; Jose R Naranjo; Ernesto Carafoli; Marisa Brini
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

6.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19

Review 7.  Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+ -sensor proteins.

Authors:  Karl-Heinz Braunewell; Andres J Klein-Szanto; Andres J Klein Szanto
Journal:  Cell Tissue Res       Date:  2008-11-07       Impact factor: 5.249

8.  DREAM controls the on/off switch of specific activity-dependent transcription pathways.

Authors:  Britt Mellström; Ignasi Sahún; Ana Ruiz-Nuño; Patricia Murtra; Rosa Gomez-Villafuertes; Magali Savignac; Juan C Oliveros; Paz Gonzalez; Asta Kastanauskaite; Shira Knafo; Min Zhuo; Alejandro Higuera-Matas; Michael L Errington; Rafael Maldonado; Javier DeFelipe; John G R Jefferys; Tim V P Bliss; Mara Dierssen; Jose R Naranjo
Journal:  Mol Cell Biol       Date:  2013-12-23       Impact factor: 4.272

9.  The role of calsenilin/DREAM/KChIP3 in contextual fear conditioning.

Authors:  Jon C Alexander; Carmel M McDermott; Tumay Tunur; Vicky Rands; Claire Stelly; Debra Karhson; Mark R Bowlby; W Frank An; J David Sweatt; Laura A Schrader
Journal:  Learn Mem       Date:  2009-02-17       Impact factor: 2.460

10.  Distribution of downstream regulatory element antagonist modulator (DREAM) in rat spinal cord and upregulation of its expression during inflammatory pain.

Authors:  Ying Zhang; Yi Li; Yan-Rui Yang; Hai-Hao Zhu; Ji-Sheng Han; Yun Wang
Journal:  Neurochem Res       Date:  2007-06-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.